Antibiotics, invention and innovation

Research Policy

Volumn 29, Issue 6, 2000, Pages 679-710

  Kingston, William ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Bacteria; Creativity; Penicillin; Streptomycin; Technological evolution

Indexed keywords

EID: 0001501755     PISSN: 00487333     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0048-7333(99)00045-1     Document Type: Article

References (69)

1. Basalla, G., 1988. The Evolution of Technology. Cambridge Univ. Press.
2. Bigger J.W., Boland C.R., O'Meara R.A.Q. Variant colonies of Staphlococcus aureus. J. Pathol. Bacteriol. 30:1927;261-268.
3. Borlaug, W.E., 1970. Nobel Lecture. Stockholm.
4. Bud R. Penicillin and the new Elizabethans. British Journal for the History of Science. 31(Part 3):1998;305-333.
5. Cardwell, D.H.L., 1971. From Watt to Clausius. Heinemann Educational, London.
6. Carter, K.C., Carter, B.R., 1994. Childbed Fever: a scientific biography of Ignaz Semmelweis. Conn. Greenwood Press, Westport.
7. Chain E.B. Thirty years of penicillin therapy. Proc. R. Soc. London. 179:1971;293-319.
8. Chain, E.B., 1980. In: Parascandola, J. (Ed.), The History of Antibiotics: A Symposium. American Institute of the History of Pharmacy, Madison, WI, pp. 15-30.
9. Chain, E.B., Florey, H., et al., 1940. Penicillin as a Chemotherapeutic Agent. Lancet, August 24, pp. 226-228.
10. Comroe, J.H., 1978. Am. Rev. Resp. Dis. pp. 117, 773-781, 957-968.
11. Crellin, J., 1980. In: Parascandola, J. (Ed.), The History of Antibiotics: A Symposium. American Institute of the History of Pharmacy, Madison, WI, pp. 5-14.
12. David, P.A., 1975. Technical Choice, Innovation and Economic Growth. Cambridge Univ. Press.
13. Dubos R. Studies on a bactericidal agent extracted from a soil bacillus. J. Exp. Med. 70:1939;1-17.
14. Fleming A. On the antibacterial action of cultures of Penicillium, with special reference to their use in the Isolation of B. influenzae. British Journal of Experimental Pathology. 10:1929;226-236.
15. Florey, H.W., 1939. Application to the Rockefeller Foundation for a Research Grant, 20th November. Copy on file with author.
16. Florey, H.W., 1941. April 18: Letter to Dr. W. Weaver of the Rockefeller Foundation, enclosing Notes on the growth of the mould which produces penicillin. Copy on file with author.
17. Florey, H.W., 1941. September 9: Report to Dr. W. Weaver of the Rockefeller Foundation on visits to U.S. and Canadian pharmaceutical firms. Copy on file with author.
18. Fosdick, R.B., 1953. The Story of the Rockefeller Foundation. Harper and Brothers, New York.
19. Friday J. Huxley and antibiosis in 1875. Br. J. Hist. Sci. 7:1974;61-71.
20. Galdston, I., 1958. Impact of antibiotics. I.U.P., New York.
21. Gardner A.D. Morphological effects of penicillin on bacteria. Nature. 146:1940;837-838.
22. Gause, G.F., 1980. Gramicidin S. and early antibiotic research in the Soviet Union. In: Parascandola, J. (Ed.), The History of Antibiotics: A Symposium. American Institute of the History of Pharmacy, Madison, WI, pp. 91-96.
23. Gilfillan, S.C., 1970. The Sociology of Invention. M.I.T. Press, Cambridge [1935].
24. Gruber R.E. Penicillin and streptomycin. M.I.T. Technology Review. 49:1947.
25. Hare, R., 1970. The Birth of Penicillin. George Allen and Unwin, London.
26. Hare R. New light on the history of penicillin. Medical History. 26:1982;1.
27. Helfland, W.H., et al., 1980. In: Parascandola, J. (Ed.), The History of Antibiotics: A Symposium. American Institute of the History of Pharmacy, Madison, WI, pp. 31-56.
28. Hobby, G.L., 1985. Penicillin: Meeting the Challenge. Yale Univ. Press, New Haven.
29. Jewkes, J., 1965. Public and Private Enterprise. Routledge and Kegan Paul, London.
30. Kingston, W., 1990. Innovation. Creativity and Law. Kluwer Academic Publishers, Dordrecht/Boston.
31. Kingston W. Innovation or bureaucracy? Creativity and Innovation Management. 4(3):1995;184-194.
32. Kiple, K.F. (Ed.), 1993. Cambridge World History of Human Disease. Cambridge Univ. Press.
33. Langlois, R., 1998. Schumpeter and Personal Capitalism. In: Eliasson, G., Green, C. (Eds.), Microfoundations of Economic Growth. University of Michigan Press, Ann Arbor.
34. Lechevalier H.A. CRC Crit. Rev. Microbiol. 3:1975;359-397.
35. Lechevalier, H.A., 1980. In: Parascandola, J. (Ed.), The History of Antibiotics: A Symposium. American Institute of the History of Pharmacy, Madison, WI, pp. 113-124.
36. Lehmann J. Para-aminosalicylic acid in the treatment of tuberculosis. Lancet. 251(1):1946;15-16.
37. Loasby, B.J., 1996. The imagined, deemed possible. In: Helmstädter, E., Perlman, M. (Eds.), Behavioral Norms, Technological Progress and Economic Dynamics. University of Michigan Press, Ann Arbor.
38. MacFarlane, G., 1979. Howard Florey: the Making of a Great Scientist. Oxford Univ. Press.
39. MacFarlane, G., 1984. Alexander Fleming: The Man and the Myth. Ghetto and Wintus, London.
40. Mees, C.E.K., 1946. The Path of Science. Chapman & Hall, London.
41. Mokyr, J., 1990. The Lever of Riches. Oxford Univ. Press, New York.
42. Olson, M., 1982. The Rise and Decline of Nations. Yale Univ. Press, New Haven.
43. Orkin L.A. Urology. 4:1974;80-84.
44. Parascandola, J., 1980. The History of Antibiotics: A Symposium. American Institute of the History of Pharmacy, Madison, WI.
45. Porter, R.W., 1946. Streptomycin Engineered into Commercial Production. Chemical Engineering, October.
46. Richards, A.N., 1964. Production of Penicillin in the United States, 1941-1946. Nature, February 1.
47. Rockefeller Foundation, 1941. April 14. Report by Dr. W. Weaver on visit to Prof. Florey's Laboratory in Oxford. Copy on file with author.
48. Rockefeller Foundation, 1941b. Extract from President's Report. Copy on file with author.
49. Rockefeller Foundation, 1943. October. Extract from Trustees' Bulletin. Copy on file with author.
50. Rosen, G., 1993. A History of Public Health. Johns Hopkins Univ. Press, Baltimore [1958].
51. Rossman, J., 1931. The Psychology of the Inventor. New York.
52. Schatz A., Bugie E., Waksman S.E. Streptomycin, a substance exhibiting antibiotic activity against Gram-positive and Gram-negative bacteria. Proc. Soc. Exp. Biol. Med. 55:1944;65-69.
53. Schumpeter, J.A., 1928. Economic Journal, pp. 38-64.
54. Schumpeter, J.A., 1943. Capitalism, Socialism and Democracy. London.
55. Schumpeter, J.A., 1947. Journal of Economic History, p. 150.
56. Schwartzman, D., 1976. Innovation in the Pharmaceutical Industry. Johns Hopkins Univ. Press, Baltimore.
57. Sheehan, J.C., 1982. The Enchanted Ring. M.I.T. Press, Boston.
58. Temin, P., 1980. Taking Your Medicine: Drug Regulation in the United States. Harvard Univ. Press, Cambridge, MA.
59. Waksman, S.A., 1940. Scientific Monthly, November.
60. Waksman, S.A., 1958. My Life with the Microbes, Robert Hale, London.
61. Waksman, S.A., 1963. A Most Fruitful Connection. Merck Journal.
62. Waksman, S.A., 1964. The Conquest of Tuberculosis. Univ. of California Press, Berkeley.
63. Waksman, S.A., 1975. The Antibiotic Era. The Waksman Foundation of Japan, Tokyo.
64. Waksman S.A., Woodruff H.B. Bacteriostatic and bactericidal substances produced by soil actinomycetes. Proc. Soc. Exp. Biol. Med. 45:1940;609-614.
65. Waksman S.A., Foster J.W., Hutchins J.J. Associative and antagonistic effect of microorganisms. Soil Sci. 43:1937;51-92.
66. Williams, T.I., 1984. Howard Florey: Penicillin and After. Oxford Univ. Press.
67. Wilson, D., 1976. Penicillin ln Perspective. Faber and Faber, London.
68. Woodruff H.B. A soil microbiologist's odyssey. Annu. Rev. Microbiol. 35:1981;1-28.
69. Wolf, J., 1996. Structures of a Scientific/Technological Revolution: Coincidence, Order and Creation of Latitude for Action in the Evolution of an Innovation: Penicillin and Antibiotics. Wissenschaftszentrum Berlin für Sozialforschung, Berlin, Publications series of the Research Unit Public Health Policy, ISSN-0935-8137.